European Archives - Page 15 of 1486 - European Medical Journal

Wearable Devices Accepted by Patients with Serious Mental Illness

Wearable Devices Accepted by Patients with Serious Mental Illness

Wearable devices were found to be acceptable and feasible among Veterans with serious mental illness in a new qualitative study.

AI Model Boosted Accuracy in Capsule Endoscopy Detection

AI Model Boosted Accuracy in Capsule Endoscopy Detection

An open-source artificial intelligence model improved lesion detection and reduced reading times during capsule endoscopy analysis.

Salivary Testosterone May Predict Pelvic Organ Prolapse

Salivary Testosterone May Predict Pelvic Organ Prolapse

Study finds reduced salivary free testosterone levels are linked to pelvic organ prolapse severity in postmenopausal women.

Maintenance Venom Immunotherapy Shows No Increased Pregnancy Risk

Maintenance Venom Immunotherapy Shows No Increased Pregnancy Risk

Italian multicentre study finds venom immunotherapy is safe in pregnancy, with no increased risk of miscarriage or preterm birth.

Understanding High-Burden Areas in Atopic Dermatitis

Atopic dermatitis (AD) is a common, heterogeneous, and chronic relapsing inflammatory disease characterised by pruritus and eczematous…

Phase 3 Trial Supports Vunakizumab for axSpA

Phase 3 Trial Supports Vunakizumab for axSpA

Patients receiving vunakizumab for radiographic axial spondyloarthritis demonstrated improved clinical responses through 32 weeks, a new trial has shown.

EuroPCR 2026: TTVI Surpasses Surgery in Tricuspid Regurgitation

Transcatheter treatment for tricuspid regurgitation increased more than tenfold in Germany between 2018–2023 and was associated with lower in-hospital mortality than surgery, according to data presented at EuroPCR 2026.

79th World Health Assembly: Maternal Deaths Set to Miss 2030 Target

The global maternal mortality ratio is around seven times lower than the rate needed to reach the SDG target, EMJ heard at the 79th World Health Assembly.

Psoriasis Text Messaging Improves CVD Prevention - EMJ

Text Messaging Boosts Cardiovascular Risk Prevention in Psoriasis

A 6-month text-messaging programme improved cardiovascular risk self-management in adults with psoriasis in a randomised trial.

Person holding a single pill in their hand

Europe set to get first oral GLP-1 weight loss pill

The European Medicines Agency has recommended the approval of Novo Nordisk’s semaglutide pill for weight loss.